on 22 Aug 2023
Last Applicant/ Owned by
2005 Market Street, 39th Floor
Philadelphia
PA
19103
Serial Number
88764198 filed on 17th Jan 2020
Registration Number
7145870 registered on 22nd Aug 2023
Correspondent Address
Connie L. Ellerbach
Filing Basis
1. intent to use
2. use application currently
Disclaimer
"BIO"
Pharmaceutical research and development; clinical research in the field of genetic medicine, gene therapy and regenerative medicines; testing, inspection, research, or development of pharmaceutical preparations and substances for genetic medicine, gene therapy and regenerative medicines; biological information analysis, namely, genetic testing for medical research purposes; scientific research in Read More
Pharmaceutical research and development; clinical research in the field of genetic medicine, gene therapy and regenerative medicines; testing, inspection, research, or development of pharmaceutical preparations and substances for genetic medicine, gene therapy and regenerative medicines; biological information analysis, namely, genetic testing for medical research purposes; scientific research in the fields of medicine, genetics, genetic medicines, regenerative medicines, gene therapy, biologics, and central nervous system diseases; providing medical and scientific research information in the fields of pharmaceuticals, genetics and clinical trials; medical and scientific research, namely, conducting clinical trials for others; compiling scientific and clinical data, in particular patient data and data from clinical studies, for research purposes in the fields of medicine, genetics, genetics medicines, regenerative medicines, gene therapy, biologics, and rare disease
01st Apr 2021
01st Apr 2021
Pharmaceutical preparations and substances for use in gene therapy, genetic medicines and regenerative therapies; pharmaceuticals and medical preparations and substances for genetically based diseases and rare disorders; pharmaceuticals and medical preparations and substances for use in the prevention and treatment of diseases and disorders of the central nervous system; medicines for human purposes, namely, for treating genetically based diseases and disorders; pharmaceutical compositions, namely, viral vectors for use in the delivery of gene therapy; pharmaceutical compositions, namely, viral vectors for use in the delivery of gene therapy for rare monogenic central nervous system diseases; pharmaceutical compositions containing adeno-associated virus (AAV) vectors for a system delivering genes to biological cells for use in the treatment of diseases, sicknesses, and disorders
29th Mar 2021
29th Mar 2021
No 88764198
No Service Mark
No 35420-00070
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 22nd Aug 2023 | REGISTERED-PRINCIPAL REGISTER |
| 22nd Aug 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 18th Jul 2023 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 17th Jul 2023 | STATEMENT OF USE PROCESSING COMPLETE |
| 17th Jul 2023 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 14th Jul 2023 | TEAS STATEMENT OF USE RECEIVED |
| 14th Jul 2023 | USE AMENDMENT FILED |
| 28th Jan 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 27th Jan 2023 | SOU EXTENSION 5 GRANTED |
| 26th Jan 2023 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
